Oncobiologics, Inc. (ONS): Stock Offering News

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Key Facts Surrounding This News Item


  • ONS had returned -7.69% year-to-date leading up to today’s news, versus a 0.00% return from the benchmark S&P 500 during the same period.

More Info About Oncobiologics, Inc. (ONS)


Oncobiologics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, manufacturing, and commercializing complex biosimilar therapeutics in the disease areas of immunology and oncology. The company was founded in 2010 and is based in Cranbury, New Jersey. View our full ONS ticker page with ratings, news, and more.

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Top Stories on StockNews.com

NYSE: SPY | SPDR S&P 500 News, Ratings, and Charts

Market Commentary: I Normally Love Sausage, But This is Crazy

It will be hard for stocks (SPY) to make it to new highs without the China trade deal being finalize. But that doesn't mean to run away from the market either. Read on for more.
: hexo | HEXO Corp. Common Shares News, Ratings, and Charts

Has Marijuana Stock HEXO Corp. (HEXO) Found a Bottom?

This past month HEXO has shown stability, holding onto $2 per share, and many investors are speculating that this could be the bottom.
NYSE: PFE | Pfizer, Inc.  News, Ratings, and Charts

7 Safest Stocks for this Newly Volatile Market

It looks like time for Risk Off stocks like PFE, PM and EPD to shine. Discover the great appeal of these stocks at this time.
: TLRY | Tilray, Inc. - Class 2  News, Ratings, and Charts

Are Shares of Tilray (TLRY) a Buy?

This week Tilray announced that former Mattel and General Mills executive Katy Dickson has joined the companies leadership team.
NYSE: SCHW | Charles Schwab Corporation (The)  News, Ratings, and Charts

Why I'm Bullish on Charles Schwab

Today's featured article covers why the author is bullish on Charles Schwab (SCHW). Continue reading for all of the details on how the company's changing the landscape of the brokerage business.

Read More Stories


More Oncobiologics, Inc. (ONS) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All ONS News
Page generated in 1.821 seconds.